Company news

Senseonics Holdings, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Eversense 365 Launches in the US: One Year. One CGM.

September 30, 2024

Eversense 365 Receives FDA Clearance: The World’s First One Year CGM

September 16, 2024

Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results

August 7, 2024

Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4: 30 P.M. Eastern Time

July 24, 2024

Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook

June 20, 2024

Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results

May 12, 2024

Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution

May 8, 2024

Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4: 30 P.M. Eastern Time

April 29, 2024

Eversense® CGM System Receives iCGM Designation by the US FDA

April 29, 2024

Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes

March 7, 2024

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

February 28, 2024

Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4: 30 P.M. Eastern Time

February 14, 2024

Medicare Coverage Significantly Expanded for the Eversense E3 CGM System

February 11, 2024

Medicare coverage significantly expanded for the Eversense E3 CGM system

February 11, 2024

Senseonics Holdings, Inc. Announces Business Updates

January 1, 2024

Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results

November 8, 2023

Senseonics Holdings, Inc Schedules Third Quarter 2023 Earnings Release and Conference Call for November 9, 2023 at 4: 30 p.m. Eastern Time

October 29, 2023

Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study

September 25, 2023

Senseonics Holdings, Inc. Enters Into $50 Million Loan Facility With Hercules Capital

September 10, 2023

Senseonics Holdings, Inc. Reports Second Quarter 2023 Financial Results

August 9, 2023

Senseonics Holdings, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 10, 2023 at 4: 30 p.m. Eastern Time

July 26, 2023

Senseonics Announces Equity Grants To Employees Under Inducement Plan

July 4, 2023

Senseonics Announces UnitedHealthcare Coverage of Eversense® E3 CGM for Adults with Diabetes

June 1, 2023

Senseonics Holdings, Inc. Reports First Quarter 2023 Financial Results

May 8, 2023

Senseonics Holdings, Inc. Schedules First Quarter 2023 Earnings Release and Conference Call for May 9, 2023, at 4: 30 p.m. Eastern Time

April 26, 2023

Senseonics Announces the First Pediatric Study Participant Insertions in the ENHANCE Clinical Trial

April 17, 2023

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results

March 14, 2023

Senseonics Holdings, Inc. and PHC Holdings Corporation To Host Joint Eversense CGM Virtual Analyst and Investor Event on March 15, 2023

February 16, 2023

Senseonics Holdings, Inc. Reports Third Quarter 2022 Financial Results

November 7, 2022

Senseonics and Ascensia Announce a Collaboration with the Nurse Practitioner Group Designed to Expand Patient Access by Providing In-Office and At-Home Insertion Options for Eversense® E3 Continuous Glucose Monitoring System (CGM)

November 2, 2022

Senseonics Holdings, Inc. Schedules Third Quarter 2022 Earnings Release and Conference Call for November 8, 2022, at 4: 30 p.m. Eastern Time

October 24, 2022

Senseonics Announces CFO Transition

August 31, 2022

Senseonics Holdings, Inc. Reports Second Quarter 2022 Financial Results

August 8, 2022

Senseonics Announces a Positive Coverage Decision for Eversense® E3 CGM from Anthem

August 2, 2022

Senseonics Holdings, Inc. Schedules Second Quarter 2022 Earnings Release and Conference Call for August 9, 2022, at 4: 30 p.m. Eastern Time

July 25, 2022

Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring System

June 15, 2022

Senseonics Holdings, Inc. Reports First Quarter 2022 Financial Results

May 9, 2022

Senseonics Holdings, Inc. Schedules First Quarter 2022 Earnings Release and Conference Call for May 10, 2022, at 4: 30 p.m. Eastern Time

April 25, 2022

Senseonics Announces the First Patient Implant of the Eversense E3 CGM System in the U.S.

April 5, 2022

Senseonics Announces Equity Grants to Employees Under Inducement Plan

March 31, 2022

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results

February 28, 2022

Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call for March 1, 2022, at 4: 30 p.m. Eastern Time

February 14, 2022

Ascensia Diabetes Care announces FDA approval of the Eversense E3 continuous glucose monitoring system for use for up to 6 months

February 13, 2022

Senseonics Announces FDA Approval of the Eversense® E3 Continuous Glucose Monitoring System for Use for Up to 6 months; Provides 2022 Business Outlook

February 10, 2022

Senseonics Announces Business Updates

January 3, 2022

Senseonics Holdings, Inc. Reports Third Quarter 2021 Financial Results

November 8, 2021

Senseonics Holdings, Inc. Schedules Third Quarter 2021 Earnings Release and Conference Call for November 9, 2021, at 4: 30 p.m. Eastern Time

October 25, 2021

Senseonics Announces a Collaboration with the University Hospitals Accountable Care Organization (UHACO) in Cleveland, Ohio

September 12, 2021

Senseonics Holdings, Inc. Reports Second Quarter 2021 Financial Results

August 8, 2021

Senseonics Holdings, Inc. Schedules Second Quarter 2021 Earnings Release and Conference Call for August 9, 2021, at 4: 30 p.m. Eastern Time

July 25, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 21 calls. Every call is listed under its year.

Decks

The 5 newest of 25 decks. Every deck is listed under its year.